Park Ha Biological Technology (BYAH) Enterprise Value (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Enterprise Value for 4 consecutive years, with -$5.7 million the latest figure, recorded in Q2 2026.

• Quarterly Enterprise Value fell 318.68% year-over-year to -$5.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$5.7 million (down 318.68% YoY) and the FY2025 annual result came in at -$3.8 million, down 591.82% from the prior year.
• Enterprise Value eased to -$5.7 million in Q2 2026 per BYAH's latest filing, from -$3.8 million in the prior quarter.
• Over the last five years, Enterprise Value for BYAH reached as high as -$547498.0 in Q4 2024 and fell as low as -$5.7 million in Q2 2026.
• A 4-year average of -$2.5 million and a median of -$1.4 million in 2025 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2024 — Enterprise Value surged 47.03% — and 2025, when it tumbled 591.82%.
• Year by year, Enterprise Value stood at -$1.0 million in 2023, then jumped by 47.03% to -$547498.0 in 2024, then slumped by 591.82% to -$3.8 million in 2025, then plunged by 49.37% to -$5.7 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$5.7 million, -$3.8 million, and -$1.4 million for Q2 2026, Q4 2025, and Q2 2025 respectively.